Ken Griffin’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.9M Sell
392,535
-3,084,937
-89% -$292M ﹤0.01% 1927
2026
Q2
$299M Buy
3,477,472
+2,098,807
+152% +$184M 0.03% 377
2026
Q1
$125M Buy
1,378,665
+1,050,289
+320% +$96.4M 0.02% 676
2025
Q4
$29.5M Buy
328,376
+212,230
+183% +$20.1M ﹤0.01% 1927
2025
Q3
$11.4M Buy
+116,146
New +$11.5M ﹤0.01% 3075
2025
Q2
– Sell
-2,042,564
Closed -$198M – 15445
2025
Q1
$231M Sell
2,042,564
-363,556
-15% -$38.9M 0.04% 328
2024
Q4
$254M Buy
2,406,120
+1,921,342
+396% +$206M 0.04% 313
2024
Q3
$52.3M Buy
484,778
+108,295
+29% +$11.8M 0.01% 1170
2024
Q2
$40.9M Sell
376,483
-348,834
-48% -$41.1M 0.01% 1313
2024
Q1
$95.7M Buy
725,317
+121,769
+20% +$15.2M 0.02% 725
2023
Q4
$73.5M Sell
603,548
-918,153
-60% -$102M 0.01% 885
2023
Q3
$171M Buy
1,521,701
+1,455,618
+2,203% +$185M 0.04% 372
2023
Q2
$9.6M Buy
66,083
+62,759
+1,888% +$8.53M ﹤0.01% 2730
2023
Q1
$429K Sell
3,324
-2,328,300
-100% -$292M ﹤0.01% 8616
2022
Q4
$297M Buy
2,331,624
+129,819
+6% +$15.1M 0.07% 207
2022
Q3
$230M Buy
2,201,805
+2,159,222
+5,071% +$237M 0.05% 260
2022
Q2
$4.47M Buy
+42,583
New +$5.05M ﹤0.01% 4015
2022
Q1
– Sell
-104,155
Closed -$12.6M – 14730
2021
Q4
$13.2M Sell
104,155
-376,755
-78% -$50.8M ﹤0.01% 2608
2021
Q3
$70.4M Buy
480,910
+463,388
+2,645% +$70.2M 0.01% 877
2021
Q2
$2.82M Sell
17,522
-1,245,020
-99% -$208M ﹤0.01% 5752
2021
Q1
$202M Sell
1,262,542
-351,284
-22% -$56M 0.05% 281
2020
Q4
$249M Buy
1,613,826
+842,291
+109% +$123M 0.06% 189
2020
Q3
$105M Sell
771,535
-72,028
-9% -$9.7M 0.03% 439
2020
Q2
$101M Buy
843,563
+803,960
+2,030% +$95.4M 0.04% 406
2020
Q1
$4M Sell
39,603
-199,572
-83% -$26.9M ﹤0.01% 3029
2019
Q4
$35.8M Sell
239,175
-681,693
-74% -$96.9M 0.02% 995
2019
Q3
$126M Buy
920,868
+459,073
+99% +$61.1M 0.06% 296
2019
Q2
$54.4M Sell
461,795
-1,138,796
-71% -$137M 0.02% 678
2019
Q1
$204M Buy
1,600,591
+1,597,107
+45,841% +$187M 0.1% 140
2018
Q4
$361K Sell
3,484
-209,844
-98% -$24.3M ﹤0.01% 6946
2018
Q3
$28M Buy
+213,328
New +$26.1M 0.01% 1129
2018
Q2
– Sell
-8,633
Closed -$968K – 9366
2018
Q1
$941K Sell
8,633
-70,847
-89% -$8.47M ﹤0.01% 4910
2017
Q4
$9.6M Sell
79,480
-240,208
-75% -$28M 0.01% 1780
2017
Q3
$37.4M Sell
319,688
-730,119
-70% -$86.8M 0.03% 702
2017
Q2
$135M Sell
1,049,807
-256,595
-20% -$31.3M 0.11% 154
2017
Q1
$160M Buy
1,306,402
+810,970
+164% +$94.7M 0.15% 106
2016
Q4
$51.1M Sell
495,432
-436,526
-47% -$48.2M 0.05% 379
2016
Q3
$121M Buy
931,958
+461,442
+98% +$58.7M 0.12% 119
2016
Q2
$56.6M Buy
470,516
+195,137
+71% +$22.7M 0.06% 294
2016
Q1
$29.4M Sell
275,379
-299,363
-52% -$29.8M 0.04% 534
2015
Q4
$59M Buy
574,742
+512,178
+819% +$51.6M 0.06% 334
2015
Q3
$5.88M Sell
62,564
-559,172
-90% -$57.7M 0.01% 1822
2015
Q2
$67.9M Sell
621,736
-384,497
-38% -$43.8M 0.06% 370
2015
Q1
$118M Buy
1,006,233
+916,303
+1,019% +$108M 0.11% 183
2014
Q4
$10.2M Sell
89,930
-33,978
-27% -$3.69M 0.01% 1406
2014
Q3
$12.5M Sell
123,908
-758,797
-86% -$76.9M 0.01% 1227
2014
Q2
$91.7M Buy
882,705
+718,823
+439% +$72.2M 0.11% 185
2014
Q1
$15.5M Buy
163,882
+145,963
+815% +$13.9M 0.02% 1003
2013
Q4
$1.67M Sell
17,919
-407,660
-96% -$36.3M ﹤0.01% 2722
2013
Q3
$35M Buy
425,579
+343,317
+417% +$27.8M 0.05% 452
2013
Q2
$6.16M Hold
82,262
– – 0.01% 1377

Other funds holding ZBH

Ken Griffin's ZBH Position: Q3 2026 in Review

Ken Griffin reduced its Zimmer Biomet (ZBH) stake by 89% in Q3 2026, selling an estimated $292M and leaving 392,535 shares worth $34.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1927.

Ken Griffin first reported a position in ZBH in Q2 2013 and has held it in 51 quarters since. The position peaked at $299M in Q2 2026. 936 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Ken Griffin held 392,535 shares of Zimmer Biomet worth $34.9M as of Q3 2026.
  • Ken Griffin sold 3,084,937 Zimmer Biomet shares in Q3 2026, an estimated $292M.
  • Zimmer Biomet made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #1927 holding.
  • Ken Griffin first reported a position in Zimmer Biomet in Q2 2013 and has held it in 51 quarters since.
  • Ken Griffin's Zimmer Biomet position peaked at $299M in Q2 2026.
  • 936 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.